Generation Bio Shares Outstanding 2020-2023 | GBIO
Generation Bio shares outstanding from 2020 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Generation Bio Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
64 |
| 2022 |
58 |
| 2021 |
56 |
| 2020 |
27 |
| 2019 |
5 |
Generation Bio Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-12-31 |
64 |
| 2023-09-30 |
66 |
| 2023-06-30 |
66 |
| 2023-03-31 |
60 |
| 2022-12-31 |
58 |
| 2022-09-30 |
59 |
| 2022-06-30 |
57 |
| 2022-03-31 |
57 |
| 2021-12-31 |
56 |
| 2021-09-30 |
57 |
| 2021-06-30 |
56 |
| 2021-03-31 |
55 |
| 2020-12-31 |
27 |
| 2020-09-30 |
45 |
| 2020-06-30 |
12 |
| 2020-03-31 |
5 |
| 2019-12-31 |
|
| 2019-09-30 |
5 |
| 2019-06-30 |
5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.200B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
